Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

FDA Warns Bangalore Drugmaker for Contamination Investigations

  • Post author:Sam
  • Post published:September 10, 2020
  • Post category:Drug GMP Report

A drug manufacturer in Bangalore, India, drew a warning letter from the FDA for failing to properly investigate contamination at its facility. Source: Drug GMP Report

Continue ReadingFDA Warns Bangalore Drugmaker for Contamination Investigations

Mylan API Plant Draws FDA Warning Letter

  • Post author:Sam
  • Post published:September 10, 2020
  • Post category:Drug GMP Report

A Mylan Laboratories active pharmaceutical ingredient (API) manufacturing facility in India drew a warning letter from the FDA for cleaning and other failures. Source: Drug GMP Report

Continue ReadingMylan API Plant Draws FDA Warning Letter

Las Vegas Compounder Warned for Poor Aseptic Practices

  • Post author:Sam
  • Post published:September 10, 2020
  • Post category:Drug GMP Report

The FDA hit Las Vegas compounder ACRx Specialty Pharmacy for poor aseptic practices and other GMP failures observed during an inspection last year. Source: Drug GMP Report

Continue ReadingLas Vegas Compounder Warned for Poor Aseptic Practices

Proposed Senate Bill Would Give FDA Drug Recall Authority

  • Post author:Sam
  • Post published:September 10, 2020
  • Post category:Drug GMP Report

A new bill introduced by Sen. Gary Peters (D-Mich.) would give the FDA the authority to recall unsafe drug products, a power it currently does not have. Source: Drug GMP…

Continue ReadingProposed Senate Bill Would Give FDA Drug Recall Authority

Siemens Healthineers’ MRI Software Cleared

  • Post author:Sam
  • Post published:August 20, 2020
  • Post category:Devices & Diagnostics Letter

The software can be used with scanners made by Siemens or other manufacturers. Source: Devices & Diagnostics Letter

Continue ReadingSiemens Healthineers’ MRI Software Cleared

J&J to Start Largest Phase 3 Vaccine Trial Yet in September

  • Post author:Sam
  • Post published:August 20, 2020
  • Post category:Devices & Diagnostics Letter

Johnson & Johnson (J&J) expects to begin the largest late-stage trial for a COVID-19 vaccine candidate to date early next month if results from its early-stage studies pan out. Source:…

Continue ReadingJ&J to Start Largest Phase 3 Vaccine Trial Yet in September

Sinopharm to Begin Phase 3 Trial of its COVID-19 Vaccine Candidate in Peru

  • Post author:Sam
  • Post published:August 20, 2020
  • Post category:Devices & Diagnostics Letter

Sinopharm has announced that it will launch another phase 3 trial of its experimental COVID-19 vaccine candidate, this time in Peru, following a greenlight from the Peruvian health regulator. Source:…

Continue ReadingSinopharm to Begin Phase 3 Trial of its COVID-19 Vaccine Candidate in Peru

LumiraDx Rapid COVID-19 Test Authorized for Emergency Use

  • Post author:Sam
  • Post published:August 20, 2020
  • Post category:Devices & Diagnostics Letter

The company said it plans to produce 2 million tests in September, increasing to 10 million tests in December. Source: Devices & Diagnostics Letter

Continue ReadingLumiraDx Rapid COVID-19 Test Authorized for Emergency Use

EU, CureVac Near Advanced Purchase Agreement for COVID-19 Vaccine

  • Post author:Sam
  • Post published:August 20, 2020
  • Post category:Devices & Diagnostics Letter

German vaccine maker CureVac and the European Union (EU) are close to finalizing a supply deal for the company’s COVID-19 vaccine candidate that will stock the EU with hundreds of…

Continue ReadingEU, CureVac Near Advanced Purchase Agreement for COVID-19 Vaccine

Smiths Medical Pulls Infusion Pumps, Citing Software Error

  • Post author:Sam
  • Post published:August 20, 2020
  • Post category:Devices & Diagnostics Letter

The company expects to release software updates late next year that will fix the problem. Source: Devices & Diagnostics Letter

Continue ReadingSmiths Medical Pulls Infusion Pumps, Citing Software Error
  • Go to the previous page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.